CEO 360 Degree Perspective - Global Pharmaceuticals & Biotechnology Industry

Publication Date	July 2009
Publisher	Frost & Sullivan
Product Type	Report
Pages	54
ISBN Number	not applicable
Product Code	FRS01159

Buy this product or for assistance call +44 20 7060 7474

PDF £3,605.00$5997 | €4035

FAX Order above formats by FAX

Summary

This research service presents the CEO 360 Degree Perspective for the global pharmaceuticals and biotechnology industry in 2009. It is an amalgamation of research from more than 50 Pharmaceutical research services generated by Frost & Sullivan, customer research findings based on approximately 1,000 end-user interviews approximately 50,000 hours of analyst research, in the last 2 years. Global healthcare analysts from Frost & Sullivan have contributed their market knowledge to cover the most important issues that are relevant in the healthcare industry today. The report also includes research findings from econometric, advanced technology and several other business divisions of Frost & Sullivan.

Content

1 PHARMACEUTICALS & BIOTECHNOLOGY INDUSTRY
- Introduction
  - 1. Title
  - 2. Disclaimer
  - 3. Certification
  - 4. Research Overview and Background
  - 5. 360 Degree Perspective and the Complex Business Universe
  - 6. Table of Contents
- Global Perspective
  - 1. Global Perspective
  - 2. Shifting Global Clinical Trial Dynamics
  - 3. Shift In Growth From Mature Markets To Emerging Markets
- Integrated Industry Perspective
  - 1. Integrated Industry Perspective
  - 2. Adaptation To Changing Business Models
  - 3. Consolidation of Pfizer and Wyeth
  - 4. Convergence of Healthcare Allows for Personalization
  - 5. Move from Transactional to Strategic Outsourcing Partnerships Encourages Standardization of LIMS
- Technology Perspective
  - 1. Technology Perspective
  - 2. Oral Oncology Drugs Increasing in Importance
  - 3. Advances in Genomics Promotes Healthcare Paradigm Shift
  - 4. Effective Screening Methods to Select the Most Promising Drug Candidates
  - 5. Growth of Vaccines Market Boosting Technology Innovation
  - 6. Gene Therapy Driving Market
- Economic Perspective
  - 1. Economic Perspective
  - 2. Venture Capital Investment in U.S. Biotechnology has Decreased to Levels Not Seen Since 2002
  - 3. Decreasing Number of Biotech IPO's due to Economic Downturn
  - 4. Restructuring
  - 5. Continued Healthcare Spending Growth
- Competitive Perspective
  - 1. Competitive Perspective
  - 2. Companies Transforming to Comprehensive Solution Providers
  - 3. Repositioning of Platform Technology Providers in Response to Biomarker Discovery and Diagnostics Development
  - 4. Expansion of Biosimilars Alters Industry Landscape
- Customer Perspective
  - 1. Customer Perspective
  - 2. Power Patient Generation
  - 3. eDetailing To Assume More Significance
  - 4. Medical Tourism ??